45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,146
Insurances with rates
35
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 11501810_1 | INJECTION, LONCASTUXIMAB TESIRINE-LPYL, 0.075 MG | $166,992 | $28,389 | — | — | 37 |
| 10643710_1 | INJECTION, RAVULIZUMAB-CWVZ, 10 MG | $163,430 | $27,783 | — | — | 37 |
| 10919713_1 | MITOMYCIN PYELOCALYCEAL INSTILLATION, 1 MG | $161,448 | $27,446 | — | — | 37 |
| 10282322_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), HIGH FREQUENCY, WITH RECHARGEABLE BATTERY AND CHARGING SYS | $159,000 | $27,030 | — | — | 29 |
| 10185490_1 | INJECTION, POLATUZUMAB VEDOTIN-PIIQ, 1 MG | $117,889 | $20,041 | — | — | 37 |
| 10316510_1 | INJECTION, EMICIZUMAB-KXWH, 0.5 MG | $116,874 | $19,869 | — | — | 37 |
| 10113910_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $106,820 | $18,159 | — | — | 29 |
| 12267826_1 | INJECTION, NIVOLUMAB AND RELATLIMAB-RMBW, 3 MG/1 MG | $91,968 | $15,635 | — | — | 37 |
| 10559421_1 | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $87,311 | $14,843 | — | — | 37 |
| 10323795_1 | INJECTION, EMICIZUMAB-KXWH, 0.5 MG | $81,812 | $13,908 | — | — | 37 |
| 10554393_1 | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $80,987 | $13,768 | — | — | 37 |
| 10361474_1 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $80,955 | $13,762 | — | — | 37 |
| 10114078_1 | PACEMAKER, SINGLE CHAMBER, RATE-RESPONSIVE (IMPLANTABLE) | $77,006 | $13,091 | — | — | 29 |
| 10263426_1 | Insertion of permanent leadless pacemaker using imaging guidance | $69,130 | $11,752 | — | — | 36 |
| 11105927_1 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $56,908 | $9,674 | — | — | 29 |
| 10114096_1 | Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment | $55,050 | $9,359 | — | — | 36 |
| 11101823_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $52,978 | $9,006 | — | — | 29 |
| 10415624_1 | INJECTION, LURBINECTEDIN, 0.1 MG | $51,341 | $8,728 | — | — | 37 |
| 10645750_1 | INJECTION, RAVULIZUMAB-CWVZ, 10 MG | $49,695 | $8,448 | — | — | 37 |
| 11957829_1 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $47,383 | $8,055 | — | — | 31 |
| 10323796_1 | INJECTION, EMICIZUMAB-KXWH, 0.5 MG | $46,750 | $7,947 | — | — | 37 |
| 10359706_1 | INTERSPINOUS PROCESS DISTRACTION DEVICE (IMPLANTABLE) | $46,379 | $7,884 | — | — | 29 |
| 10463711_1 | IMPLANTABLE/INSERTABLE DEVICE, NOT OTHERWISE CLASSIFIED | $46,379 | $7,884 | — | — | 29 |
| 11365810_1 | IMPLANTABLE/INSERTABLE DEVICE, NOT OTHERWISE CLASSIFIED | $46,379 | $7,884 | — | — | 29 |
| 11469807_1 | JOINT DEVICE (IMPLANTABLE) | $45,779 | $7,782 | — | — | 29 |
| 11033240_1 | JOINT DEVICE (IMPLANTABLE) | $43,784 | $7,443 | — | — | 29 |
| 11155900_1 | JOINT DEVICE (IMPLANTABLE) | $43,784 | $7,443 | — | — | 29 |
| 11797809_1 | JOINT DEVICE (IMPLANTABLE) | $43,783 | $7,443 | — | — | 29 |
| 12179895_1 | JOINT DEVICE (IMPLANTABLE) | $43,783 | $7,443 | — | — | 29 |
| 12207831_1 | JOINT DEVICE (IMPLANTABLE) | $43,783 | $7,443 | — | — | 29 |
| 10667722_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $43,368 | $7,373 | — | — | 29 |
| 10451647_1 | JOINT DEVICE (IMPLANTABLE) | $40,416 | $6,871 | — | — | 29 |
| 10613525_1 | JOINT DEVICE (IMPLANTABLE) | $40,416 | $6,871 | — | — | 29 |
| 10715722_1 | JOINT DEVICE (IMPLANTABLE) | $40,416 | $6,871 | — | — | 29 |
| 10475586_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 10554403_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 10667721_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 10673731_1 | INTERSPINOUS PROCESS DISTRACTION DEVICE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 11043860_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 11619818_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $40,195 | $6,833 | — | — | 29 |
| 11957826_1 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $39,901 | $6,783 | — | — | 31 |
| 10475606_1 | JOINT DEVICE (IMPLANTABLE) | $39,345 | $6,689 | — | — | 29 |
| 11481814_1 | JOINT DEVICE (IMPLANTABLE) | $39,345 | $6,689 | — | — | 29 |
| 10329500_1 | JOINT DEVICE (IMPLANTABLE) | $39,239 | $6,671 | — | — | 29 |
| 11785805_1 | INJECTION, PEGFILGRASTIM-APGF (NYVEPRIA), BIOSIMILAR, 0.5 MG | $36,738 | $6,245 | — | — | 37 |
| 10337588_1 | INJECTION, ENFORTUMAB VEDOTIN-EJFV, 0.25 MG | $36,408 | $6,189 | — | — | 37 |
| 11321814_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $34,014 | $5,782 | — | — | 29 |
| 11529805_1 | INJECTION, NIVOLUMAB, 1 MG | $32,187 | $5,472 | — | — | 37 |
| 12225822_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $31,154 | $5,296 | — | — | 29 |
| 10668580_1 | IMPLANTABLE/INSERTABLE DEVICE, NOT OTHERWISE CLASSIFIED | $30,571 | $5,197 | — | — | 29 |
Showing top 50 of 6,146 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.